These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27666114)

  • 1. Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study.
    Elias SG; Kok L; de Wit NJ; Witteman BJ; Goedhard JG; Romberg-Camps MJ; Muris JW; Moons KG
    BMC Med; 2016 Sep; 14(1):141. PubMed ID: 27666114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic work-up of patients presenting in primary care with lower abdominal symptoms: which faecal test and triage strategy should be used?
    Fraser CG
    BMC Med; 2016 Sep; 14(1):139. PubMed ID: 27666321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: the Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study.
    Kok L; Elias SG; Witteman BJ; Goedhard JG; Muris JW; Moons KG; de Wit NJ
    Clin Chem; 2012 Jun; 58(6):989-98. PubMed ID: 22407858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of NICE guideline NG12 to the initial assessment of patients with lower gastrointestinal symptoms: not FIT for purpose?
    Quyn AJ; Steele RJ; Digby J; Strachan JA; Mowat C; McDonald PJ; Carey FA; Godber IM; Younes HB; Fraser CG
    Ann Clin Biochem; 2018 Jan; 55(1):69-76. PubMed ID: 28661203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
    Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
    Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer.
    Hijos-Mallada G; Saura N; Lué A; Velamazan R; Nieto R; Navarro M; Arechavaleta S; Chueca E; Gomollon F; Lanas A; Sostres C
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of point of care faecal immunochemical testing using a portable high-speed quantitative analyser for diagnosis in 2-week wait patients.
    Maclean W; Mackenzie P; Limb C; Zahoor Z; Whyte MB; Rockall T; Benton SC; Jourdan I
    Colorectal Dis; 2021 Sep; 23(9):2376-2386. PubMed ID: 34157205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Published diagnostic models safely excluded colorectal cancer in an independent primary care validation study.
    Elias SG; Kok L; Witteman BJM; Goedhard JG; Romberg-Camps MJL; Muris JWM; de Wit NJ; Moons KGM
    J Clin Epidemiol; 2017 Feb; 82():149-157.e8. PubMed ID: 27989951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal calprotectin is not necessarily required as a screen for significant bowel disease in primary care.
    Waite MMA; Langmead L; Ayling RM
    Ann Clin Biochem; 2022 May; 59(3):171-177. PubMed ID: 34958262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of the faecal immunochemical test for colorectal cancer in symptomatic patients: comparison with NICE and SIGN referral criteria.
    Cubiella J; Salve M; Díaz-Ondina M; Vega P; Alves MT; Iglesias F; Sánchez E; Macía P; Blanco I; Bujanda L; Fernández-Seara J
    Colorectal Dis; 2014 Aug; 16(8):O273-82. PubMed ID: 24456168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a faecal immunochemical test for haemoglobin can aid in the investigation of patients with lower abdominal symptoms.
    Godber IM; Todd LM; Fraser CG; MacDonald LR; Younes HB
    Clin Chem Lab Med; 2016 Apr; 54(4):595-602. PubMed ID: 26457785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.
    Rodríguez-Alonso L; Rodríguez-Moranta F; Ruiz-Cerulla A; Lobatón T; Arajol C; Binefa G; Moreno V; Guardiola J
    Dig Liver Dis; 2015 Sep; 47(9):797-804. PubMed ID: 26055489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low faecal haemoglobin concentration potentially rules out significant colorectal disease.
    McDonald PJ; Digby J; Innes C; Strachan JA; Carey FA; Steele RJ; Fraser CG
    Colorectal Dis; 2013 Mar; 15(3):e151-9. PubMed ID: 23199241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Accuracy of a Qualitative Fecal Immunochemical Test Varies With Location of Neoplasia But Not Number of Specimens.
    Wong MC; Ching JY; Chan VC; Lam TY; Shum JP; Luk AK; Wong SS; Ng SC; Ng SS; Wu JC; Chan FK; Sung JJ
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1472-9. PubMed ID: 25724708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn's disease patients on maintenance treatment with adalimumab.
    Ferreiro-Iglesias R; Barreiro-de Acosta M; Lorenzo-Gonzalez A; Dominguez-Muñoz JE
    Scand J Gastroenterol; 2016; 51(4):442-7. PubMed ID: 26595391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S; Smirnova E; Popov D; Semenov A; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.